Compare H1B visa sponsorship data between Goldman Sachs and Pfizer. See how they stack up on salary, approval rates, and more.

Key Statistics Comparison

Total H1B Filings
+1113%
14,154
Goldman Sachs
1,167
Pfizer
Median Salary
$113,200
Goldman Sachs
+17.0%
$136,350
Pfizer
Approval Rate
99.0%
Goldman Sachs
100.0%
Pfizer
Years Sponsoring
18
Goldman Sachs
18
Pfizer

Historical Trends

H1B Filings Over Time

Goldman Sachs
Pfizer
2008 2011 2014 2017 2020 2025 8 983 1,957

Median Salary Trend

Goldman Sachs
Pfizer
2008 2011 2014 2017 2020 2025 $81k $124k $168k

Where & What They Hire

Top H1B Job Categories

Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Pfizer
Biochemists and Biophysicists 15 filings
Medical Scientists, Except Epidemiologists 7 filings
Statisticians 5 filings
Biostatisticians 3 filings
Natural Sciences Managers 2 filings

Top H1B Work Locations

Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Pfizer
Andover, MA 10 filings
Pearl River, NY 5 filings
Groton, CT 5 filings
Cambridge, MA 4 filings
Bothell, WA 3 filings

Year-by-Year Breakdown

Year Goldman Sachs Pfizer
Filings Salary Approval Filings Salary Approval
FY2025 731 $113,200 99.0% 42 $136,350 100.0%
FY2024 310 $145,000 100.0% 18 $152,669 100.0%
FY2023 186 $150,000 100.0% 22 $130,995 100.0%
FY2022 306 $149,000 100.0% 9 $121,437 100.0%
FY2021 527 $125,000 100.0% 17 $116,025 100.0%
FY2020 249 $138,000 100.0% 18 $119,520 100.0%
FY2019 1,726 $115,000 98.7% 92 $106,043 94.9%
FY2018 1,779 $110,000 98.7% 72 $104,033 97.0%
FY2017 1,085 $103,600 99.0% 63 $99,800 96.7%
FY2016 1,086 $105,050 98.2% 58 $97,850 100.0%
Showing most recent 10 years of 18 total

Frequently Asked Questions

Which company pays higher H1B salaries, Goldman Sachs or Pfizer?
Pfizer pays higher H1B salaries with a median of $136,350 compared to Goldman Sachs's $113,200.
Which company sponsors more H1B visas, Goldman Sachs or Pfizer?
Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Pfizer's 1,167.
How do Goldman Sachs and Pfizer H1B approval rates compare?
Goldman Sachs has a 99.0% H1B approval rate while Pfizer has 100.0%. Pfizer has a higher approval rate.

View Full Details